MTOR and Alzheimer disease: Inhibitions of the mTOR pathway by rapamycin, an mTOR inhibitor, decreased the level of p-mTOR significantly, reduced Aβ deposition, and delayed the progression of AD as a consequence of autophagy activation [35].